Tyra Biosciences (TYRA) Other Non Operating Income (2022 - 2023)
Tyra Biosciences (TYRA) posted Other Non Operating Income of -$5000.0 for Q3 2023, down 200.0% on a QoQ basis from $5000.0 in Q3 2022, and down 200.0% year-over-year from $5000.0 in Q3 2022.
Tyra Biosciences (TYRA) Other Non Operating Income (2022 - 2023) Analysis & Trends
Tyra Biosciences' Other Non Operating Income history runs 2 years deep, the most recent figure standing at -$5000.0 for Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Tyra Biosciences | 1.95 Bn | 1.95 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -5,000.00 |
| Sep 30, 2022 | 5,000.00 |